AIG
NVIV

American International Group’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

American International Group’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$80K – 3165
2017
Q1 		$80K Hold
1
– – ﹤0.01% 2703
2016
Q4 		$78K Hold
1
– – ﹤0.01% 2735
2016
Q3 		$126K Hold
1
– – ﹤0.01% 2469
2016
Q2 		$107K Hold
1
– – ﹤0.01% 2559
2016
Q1 		$126K Hold
1
– – ﹤0.01% 3225
2015
Q4 		$122K Hold
1
– – ﹤0.01% 3329
2015
Q3 		$149K Hold
1
– – ﹤0.01% 3096
2015
Q2 		$267K Buy
+1
New +$264K ﹤0.01% 2749

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's NVIV Position: Q2 2017 in Review

American International Group sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 1 share — an estimated $80K sold.

American International Group first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $267K in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

  • American International Group reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
  • American International Group sold 1 InVivo Therapeutics Holdings Corp share in Q2 2017, an estimated $80K.
  • American International Group first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
  • American International Group's InVivo Therapeutics Holdings Corp position peaked at $267K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.